JP2025500465A5 - - Google Patents
Info
- Publication number
- JP2025500465A5 JP2025500465A5 JP2024538173A JP2024538173A JP2025500465A5 JP 2025500465 A5 JP2025500465 A5 JP 2025500465A5 JP 2024538173 A JP2024538173 A JP 2024538173A JP 2024538173 A JP2024538173 A JP 2024538173A JP 2025500465 A5 JP2025500465 A5 JP 2025500465A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- domain
- sequence
- epor
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB202118797 | 2021-12-22 | ||
| GB2118797.6 | 2021-12-22 | ||
| PCT/GB2022/053359 WO2023118878A1 (en) | 2021-12-22 | 2022-12-22 | Constitutive cytokine receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025500465A JP2025500465A (ja) | 2025-01-09 |
| JP2025500465A5 true JP2025500465A5 (cg-RX-API-DMAC7.html) | 2025-12-10 |
Family
ID=84887911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024538173A Pending JP2025500465A (ja) | 2021-12-22 | 2022-12-22 | 構成的サイトカイン受容体 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4453022A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025500465A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118434761A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022422880A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3241186A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202334398A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023118878A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024133472A1 (en) * | 2022-12-22 | 2024-06-27 | Quell Therapeutics Limited | Constitutive cytokine receptors |
| CN117567643A (zh) * | 2023-11-13 | 2024-02-20 | 四川大学 | 一种新型il-3受体修饰的嵌合抗原受体及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9803351D0 (en) | 1998-02-17 | 1998-04-15 | Oxford Biomedica Ltd | Anti-viral vectors |
| WO1999067360A2 (en) * | 1998-06-25 | 1999-12-29 | Hemosol Inc. | Media and methods for expansion of erythroid stem cells for the production of hemoglobin |
| GB0009760D0 (en) | 2000-04-19 | 2000-06-07 | Oxford Biomedica Ltd | Method |
| JP5626164B2 (ja) | 2011-07-26 | 2014-11-19 | 日本精工株式会社 | ステアリングコラム用支持装置 |
| WO2019055946A1 (en) * | 2017-09-18 | 2019-03-21 | F1 Oncology, Inc. | METHODS AND COMPOSITIONS FOR THE GENETIC MODIFICATION AND EXPANSION OF LYMPHOCYTES AND THE REGULATION OF THE ACTIVITY THEREOF |
| AU2019227979B2 (en) | 2018-03-02 | 2024-09-05 | Allogene Therapeutics, Inc. | Inducible chimeric cytokine receptors |
| WO2019241549A1 (en) | 2018-06-15 | 2019-12-19 | A2 Biotherapeutics, Inc. | Foxp3-expressing car-t regulatory cells |
| JP7484712B2 (ja) | 2018-06-29 | 2024-05-16 | Agc株式会社 | 複合部材および成形用型、複合部材の製造方法およびガラス材料の成形方法ならびに光学素子の製造方法、光学系の製造方法、および撮像装置の製造方法 |
| GB201814203D0 (en) | 2018-08-31 | 2018-10-17 | King S College London | Engineered regulatory t cell |
| GB202007842D0 (en) | 2020-05-26 | 2020-07-08 | Quell Therapeutics Ltd | Polypeptide useful in adoptive cell therapy |
-
2022
- 2022-12-22 EP EP22839428.4A patent/EP4453022A1/en active Pending
- 2022-12-22 CA CA3241186A patent/CA3241186A1/en active Pending
- 2022-12-22 CN CN202280083534.8A patent/CN118434761A/zh active Pending
- 2022-12-22 AU AU2022422880A patent/AU2022422880A1/en active Pending
- 2022-12-22 JP JP2024538173A patent/JP2025500465A/ja active Pending
- 2022-12-22 WO PCT/GB2022/053359 patent/WO2023118878A1/en not_active Ceased
- 2022-12-22 TW TW111149337A patent/TW202334398A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022541657A5 (cg-RX-API-DMAC7.html) | ||
| US7638281B2 (en) | Polypeptide, cDNA encoding the same and use of them | |
| RU2010122053A (ru) | Иммуносупрессорные полипептиды и нуклеиновые кислоты | |
| MX2012002428A (es) | Compuestos de union il-17 y usos medicos de los mismos. | |
| JPH08507676A (ja) | 可溶性オリゴマー蛋白質の調製法 | |
| CA2337100A1 (en) | Polypeptides of lymphodendritic cell adhesion molecules (ldcams) and polynucleotides encoding the same | |
| CA3140064A1 (en) | Lockr-mediated recruitment of car t cells | |
| JP2007519611A (ja) | 分泌された三量体受容体類似体及び生物学的活性融合タンパク質を製造するための方法及び組成物 | |
| KR20190012193A (ko) | 안정화된 융합-전 rsv f 단백질 | |
| JP3854995B2 (ja) | 細胞透過性キャリアペプチド | |
| EP1918297A1 (en) | Neuronal differentiation-inducing peptide and use thereof | |
| WO2024204896A1 (en) | Genetically modified cells into which a nucleic acid encoding a stefin a protein variants specifically binding to tnfr2 or a fusion protein comprising the same has been introduced, and uses thereof | |
| KR101064914B1 (ko) | 자가면역질환, 알러지성 질환 및 염증성 질환 치료용 약제 조성물 및 이의 전달 방법 | |
| EP1809660A2 (en) | A thymus-specific protein | |
| AU2021219885B2 (en) | Optimization of chimeric antigen receptor | |
| JP2022049715A (ja) | インスリン分泌促進ペプチド | |
| CN117285645A (zh) | 一种铁蛋白纳米颗粒疫苗的制备和应用 | |
| CN119285745B (zh) | TGF-β受体激动剂多肽及其用途 | |
| CN119285746B (zh) | 作为TGF-β受体激动剂肽的化合物及其用途 | |
| WO1999018205A1 (fr) | POLYPEPTIDE, ADNc LE CODANT ET LEUR UTILISATION | |
| JPH05508539A (ja) | 安定および生体活性改変ソマトトロピン類 | |
| US9856293B2 (en) | Methods for inducing nestin expression of astrocytes by nestin-inducing synthetic peptides derived from the BC-box of the SOCS6 protein | |
| KR20250047619A (ko) | Tnfr2 결합 에이전트를 인코딩하는 핵산을 포함하는 유전자 변형된 세포 및 이의 용도 | |
| AU2017358552B2 (en) | Protransducine-C: gene transfer activator | |
| TW202513793A (zh) | 已經引入至有編碼特異性結合tnfr2的stefin a蛋白變體或包括該蛋白變體的融合蛋白的核酸中的經遺傳修飾的細胞,及其用途 |